Previous Article | Next Article 
Infect Immun, August 1998, p. 3925-3930, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Passive Immunization with Antibodies against Three
Distinct Epitopes on Plasmodium yoelii Merozoite Surface
Protein 1 Suppresses Parasitemia
Lilian M.
Spencer Valero,
Solabomi A.
Ogun,
Suzanne L.
Fleck,
Irene T.
Ling,
Terry
J.
Scott-Finnigan,
Michael J.
Blackman, and
Anthony A.
Holder*
Division of Parasitology, National Institute
for Medical Research, London NW7 1AA, United Kingdom
Received 10 February 1998/Returned for modification 31 March
1998/Accepted 6 May 1998
We have produced monoclonal antibodies against Plasmodium
yoelii merozoite surface protein 1 (MSP-1) and have assessed
their ability to suppress blood stage parasitemia by passive
immunization. Six immunoglobulin G antibodies were characterized in
detail: three (B6, D3, and F5) were effective in suppressing a lethal blood stage challenge infection, two (B10 and G3) were partially effective, and one (B4) was ineffective. MSP-1 is the precursor to a
complex of polypeptides on the merozoite surface; all of the antibodies
bound to this precursor and to an ~42-kDa fragment (MSP-142) that is derived from the C terminus of MSP-1.
MSP-142 is further cleaved to an N-terminal ~33-kDa
polypeptide (MSP-133) and a C-terminal ~19-kDa
polypeptide (MSP-119) comprised of two epidermal growth
factor (EGF)-like modules. D3 reacted with MSP-142 but not
with either of the constituents MSP-133 and
MSP-119, B4 recognized an epitope within the N terminus of
MSP-133, and B6, B10, F5, and G3 bound to
MSP-119. B10 and G3 bound to epitopes that required both
C-terminal EGF-like modules for their formation, whereas B6 and F5
bound to epitopes in the first EGF-like module. These results indicate
that at least three distinct epitopes on P. yoelii MSP-1
are recognized by antibodies that suppress parasitemia in vivo.
*
Corresponding author. Mailing address: Division of
Parasitology, National Institute for Medical Research, Mill Hill,
London NW7 1AA, United Kingdom. Phone: (44) 181 959 3666, ext. 2175. Fax: (44) 181 913 8593. E-mail:
aholder{at}nimr.mrc.ac.uk.
Infect Immun, August 1998, p. 3925-3930, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lynch, M. M., Cernetich-Ott, A., Weidanz, W. P., Burns, J. M. Jr.
(2009). Prediction of Merozoite Surface Protein 1 and Apical Membrane Antigen 1 Vaccine Efficacies against Plasmodium chabaudi Malaria Based on Prechallenge Antibody Responses. CVI
16: 293-302
[Abstract]
[Full Text]
-
Faber, B. W., Remarque, E. J., Morgan, W. D., Kocken, C. H. M., Holder, A. A., Thomas, A. W.
(2007). Malaria Vaccine-Related Benefits of a Single Protein Comprising Plasmodium falciparum Apical Membrane Antigen 1 Domains I and II Fused to a Modified Form of the 19-Kilodalton C-Terminal Fragment of Merozoite Surface Protein 1. Infect. Immun.
75: 5947-5955
[Abstract]
[Full Text]
-
BONILLA, J. A., VALIDUM, L., CUMMINGS, R., PALMER, C. J.
(2006). GENETIC DIVERSITY OF PLASMODIUM VIVAX PVCSP AND PVMSP1 IN GUYANA, SOUTH AMERICA. Am J Trop Med Hyg
75: 830-835
[Abstract]
[Full Text]
-
Narum, D. L., Ogun, S. A., Batchelor, A. H., Holder, A. A.
(2006). Passive Immunization with a Multicomponent Vaccine against Conserved Domains of Apical Membrane Antigen 1 and 235-Kilodalton Rhoptry Proteins Protects Mice against Plasmodium yoelii Blood-Stage Challenge Infection.. Infect. Immun.
74: 5529-5536
[Abstract]
[Full Text]
-
Pleass, R. J., Ogun, S. A., McGuinness, D. H., van de Winkel, J. G. J., Holder, A. A., Woof, J. M.
(2003). Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection. Blood
102: 4424-4430
[Abstract]
[Full Text]
-
Stanisic, D. I., Martin, L. B., Good, M. F.
(2003). The Role of the 19-kDa Region of Merozoite Surface Protein 1 and Whole-Parasite-Specific Maternal Antibodies in Directing Neonatal Pups' Responses to Rodent Malaria Infection. J. Immunol.
171: 5461-5469
[Abstract]
[Full Text]
-
Wipasa, J., Hirunpetcharat, C., Mahakunkijcharoen, Y., Xu, H., Elliott, S., Good, M. F.
(2002). Identification of T Cell Epitopes on the 33-kDa Fragment of Plasmodium yoelii Merozoite Surface Protein 1 and Their Antibody-Independent Protective Role in Immunity to Blood Stage Malaria. J. Immunol.
169: 944-951
[Abstract]
[Full Text]
-
Near, K. A., Stowers, A. W., Jankovic, D., Kaslow, D. C.
(2002). Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine Model. Infect. Immun.
70: 692-701
[Abstract]
[Full Text]
-
Ahlborg, N., Ling, I. T., Howard, W., Holder, A. A., Riley, E. M.
(2002). Protective Immune Responses to the 42-Kilodalton (kDa) Region of Plasmodium yoelii Merozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa Region. Infect. Immun.
70: 820-825
[Abstract]
[Full Text]
-
Kedzierski, L., Black, C. G., Coppel, R. L.
(2000). Immunization with Recombinant Plasmodium yoelii Merozoite Surface Protein 4/5 Protects Mice against Lethal Challenge. Infect. Immun.
68: 6034-6037
[Abstract]
[Full Text]
-
Narum, D. L., Ogun, S. A., Thomas, A. W., Holder, A. A.
(2000). Immunization with Parasite-Derived Apical Membrane Antigen 1 or Passive Immunization with a Specific Monoclonal Antibody Protects BALB/c Mice against Lethal Plasmodium yoelii yoelii YM Blood-Stage Infection. Infect. Immun.
68: 2899-2906
[Abstract]
[Full Text]
-
Ahlborg, N., Ling, I. T., Holder, A. A., Riley, E. M.
(2000). Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119. Infect. Immun.
68: 2102-2109
[Abstract]
[Full Text]